abrdn plc Has $32.10 Million Holdings in Integer Holdings Co. (NYSE:ITGR)

abrdn plc lessened its holdings in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 18.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 240,301 shares of the medical equipment provider's stock after selling 52,940 shares during the quarter. abrdn plc owned about 0.72% of Integer worth $32,099,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Blue Trust Inc. lifted its holdings in Integer by 4.4% in the fourth quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider's stock worth $220,000 after purchasing an additional 71 shares during the period. Contravisory Investment Management Inc. raised its position in shares of Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after buying an additional 80 shares in the last quarter. HighTower Advisors LLC lifted its stake in shares of Integer by 0.8% in the 3rd quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider's stock worth $1,579,000 after acquiring an additional 90 shares during the period. Exchange Traded Concepts LLC boosted its holdings in shares of Integer by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 5,800 shares of the medical equipment provider's stock valued at $769,000 after acquiring an additional 145 shares in the last quarter. Finally, Versant Capital Management Inc increased its stake in shares of Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock valued at $49,000 after acquiring an additional 183 shares during the period. Institutional investors own 99.29% of the company's stock.

Integer Trading Down 0.4 %

NYSE ITGR traded down $0.54 on Friday, hitting $140.37. 155,579 shares of the company were exchanged, compared to its average volume of 220,089. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The firm has a market capitalization of $4.71 billion, a P/E ratio of 43.32, a price-to-earnings-growth ratio of 1.79 and a beta of 1.13. Integer Holdings Co. has a twelve month low of $94.56 and a twelve month high of $146.36. The company's 50 day moving average price is $137.94 and its 200-day moving average price is $131.06.

Wall Street Analyst Weigh In

A number of research firms have weighed in on ITGR. Piper Sandler restated an "overweight" rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Wells Fargo & Company restated an "overweight" rating and issued a $160.00 price objective on shares of Integer in a report on Tuesday, December 3rd. Benchmark lifted their target price on Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Monday, October 21st. Truist Financial upped their price target on shares of Integer from $147.00 to $163.00 and gave the company a "buy" rating in a report on Wednesday, December 11th. Finally, KeyCorp lifted their price objective on shares of Integer from $144.00 to $154.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $146.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.